Structure–activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416
摘要:
A series of combretastatin A-4 analogs derived from the ATP competitive, VEGF receptor tyrosine kinase inhibitor, SU5416 were synthesized. The cytotoxic effects of the analogs were evaluated against PC-3 and MDA-MB-231 cancer cell lines, as well as their abilities to inhibit tubulin polymerization. Results are compared to those of compound 1, our lead compound previously reported. (c) 2006 Elsevier Ltd. All rights reserved.
Structure–activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416
作者:Bulbul Pandit、Yanjun Sun、Ping Chen、Dan L. Sackett、Zhigen Hu、Wendy Rich、Chenglong Li、Andrew Lewis、Kevin Schaefer、Pui-Kai Li
DOI:10.1016/j.bmc.2006.06.017
日期:2006.10
A series of combretastatin A-4 analogs derived from the ATP competitive, VEGF receptor tyrosine kinase inhibitor, SU5416 were synthesized. The cytotoxic effects of the analogs were evaluated against PC-3 and MDA-MB-231 cancer cell lines, as well as their abilities to inhibit tubulin polymerization. Results are compared to those of compound 1, our lead compound previously reported. (c) 2006 Elsevier Ltd. All rights reserved.